FIELD: biotechnology, microbiology. SUBSTANCE: invention relates to the strain of lactobacillus showing ability to produce interferon in human unicellular cells and to effect on physiological and immunological processes in body. The strain Lactobacillus acidophilus N.V.EP 317/402 "Narine" TNCi is deposited in VKPM at N B-8017. The strain is obtained by of many years selection of the parent culture L. acidophilus N.V. 317/402 "Narine". The strain is selected by its antibiotic activity to pathogens of gastroenteric diseases, resistance to antibiotics, vitamin producing capacity, growth rate and so on. Ferment of the strain L. acidophilus N.V.EP 317/402 "Narine" TNCi can be used for preparing dietetic and curative foodstuffs or for direct use in nutrition, as medicinal agent for treatment and prophylaxis of dysbacteriosis and its complications. EFFECT: strain indicated above, enhanced effectiveness of preparations. 4 dwg, 3 tbl, 2 ex
Authors
Dates
2001-12-10—Published
2001-01-04—Filed